Concord Biotech informs about transcripts of earnings call
In continuation of its letter dated November 15, 2024 regarding Audio recording of the Audited (Standalone and Consolidated) Financial Results of the company for the Second Quarter and half year ended September 30, 2025, Earnings call for Investors and Analysts and pursuant to Regulation 30 (6) of the SEBI (Listing Obligations and Disclosure Requirements) 2015, Concord Biotech has informed that the transcripts of the Earnings call for the said period enclosed and available on the website of the company at the following link after sending this letter. This transcript and the audio recording of the call, both have been uploaded on our website as follows: https://concordbiotech.com/investor/.
The above information is a part of company’s filings submitted to BSE.
